Search results
Component of keto diet plus immunotherapy may reduce prostate cancer
Medical Xpress· 2 days agoICB therapy blocks certain proteins from binding with other proteins and paves the way for our...
Mosaic ImmunoEngineering Agrees to Acquire Clinical Necroptosis Cancer Therapy Assets from Oncotelic...
Digital Journal· 12 hours agoHUNTINGTON BEACH, CA / ACCESSWIRE / April 29, 2024 / Mosaic ImmunoEngineering, Inc. ("Mosaic" or the "Company"), (OTC PINK:CPMV), a development-stage biotechnology company focused on the development ...
Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack
Newswise· 6 days agoA Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within...
Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital's Transplant and...
Newswise· 5 days agoNewswise — (New Brunswick, NJ) - The Foundation for the Accreditation of Cellular Therapy (FACT) has...
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to...
CBS 47 Fresno· 13 hours agoRepertoire® Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune medicines, announced ...
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to...
FOX 4 Kansas City· 13 hours agoRepertoire® Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune medicines, announced ...
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function - Nature
Nature· 6 days agoProstaglandin E2 from the tumour microenvironment impairs interleukin-2 sensing by tumour-infiltrating lymphocytes, restricting proliferative response and promoting T < ...
US FDA approves ImmunityBio's bladder cancer therapy - BusinessWorld Online
BusinessWorld· 7 days agoThe US health regulator approved on Monday ImmunityBio’s combination therapy to treat a type of...
Browse Articles | Nature Reviews Clinical Oncology
Nature· 18 hours agoBrowse the archive of articles on Nature Reviews Clinical Oncology
...Present In Vivo CAR Data in Oncology and Autoimmunity Programs at the American Society of Gene...
The Pilot News· 6 days agoInterius BioTherapeutics, a leading developer of in vivo cell-specific gene medicines, today announced the presentation of preclinical data across six abstracts at the American Society of Gene ...